Extent of emphysema on HRCT affects loss of fat-free mass and fat mass in COPD

Internal Medicine

Volumn 48, Issue 1, 2009, Pages 41-48

  Kurosaki, Hiroko ^a   Ishii, Takeo ^a   Motohashi, Norihisa ^a   Motegi, Takashi ^a   Yamada, Kouichi ^a   Kudoh, Shoji ^a   Jones, Rupert C M ^b   Kida, Kozui ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Fat mass; Fat free mass; Low attenuation area; Muscle strength

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN;

AGE; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; EXERCISE TEST; EXERCISE TOLERANCE; FAT FREE MASS; FAT MASS; GRIP STRENGTH; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMPEDANCE; INFLAMMATION; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; MUSCLE STRENGTH; NUTRITIONAL STATUS; RESPIRATORY AIRFLOW; SKELETAL MUSCLE; SMOKING;

ADIPOSE TISSUE; AGED; BODY COMPOSITION; BODY FAT DISTRIBUTION; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NUTRITIONAL STATUS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 61749097068     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.1102     Document Type: Article

References (42)

1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2006. www.goldcopd.org/. Date last updated: December 2006. Date last accessed: July 30, 2007.
2. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158: 629-634, 1998.
3. Engelen MP, Schols AM, Does JD, Wouters EF. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 71: 733-738, 2000.
4. Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171: 972-977, 2005.
5. Debigare R, Marquis K, Cote CH, et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 124: 83-89, 2003.
6. Gosker HR, Kubat B, Schaart G, et al. Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease. Eur Respir J 22: 280-285, 2003.
7. Gosker HR, Engelen MP, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 76: 113-119, 2002.
8. Agusti AG, Sauleda J, Miralles C, et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166: 485-489, 2002.
9. Kaizu Y, Ohkawa S, Odamaki M, et al. Association between inflammatory mediators and muscle mass in long-term hemodialysis patients. Am J Kidney Dis 42: 295-302, 2003.
10. Filippatos GS, Kanatselos C, Manolatos DD, et al. Studies on apoptosis and fibrosis in skeletal musculature: a comparison of heart failure patients with and without cardiac cachexia. Int J Cardiol 90: 107-113, 2003.
11. Visser M, Kritchevsky SB, Newman AB, et al. Lower serum albumin concentration and change in muscle mass: the Health, Aging and Body Composition Study. Am J Clin Nutr 82: 531-537, 2005.
12. Bua E, McKiernan SH, Aiken JM. Calorie restriction limits the generation but not the progression of mitochondrial abnormalities in aging skeletal muscle. Faseb J 18: 582-584, 2004.
13. Husom AD, Ferrington DA, Thompson LV. Age-related differences in the adaptive potential of type I skeletal muscle fibers. Exp Gerontol 40: 227-235, 2005.
14. Bar-Shai M, Carmeli E, Coleman R, Reznick AZ. Mechanisms in muscle atrophy in immobilization and aging. Ann N Y Acad Sci 1019: 475-478, 2004.
15. Gillette Guyonnet S, Abellan Van Kan G, Alix E, et al. IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. J Nutr Health Aging 11: 38-48, 2007.
16. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 1791-1797, 1998.
17. Agusti AG, Noguera A, Sauleda J, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 21: 347-360, 2003.
18. Nicklas BJ, Penninx BW, Cesari M, et al. Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study. Am J Epidemiol 160: 741-749, 2004.
19. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61: 17-22, 2006.
20. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 162: 1102-1108, 2000.
21. Oh DK, Ciaraldi T, Henry RR. Adiponectin in health and disease. Diabetes Obes Metab 9: 282-289, 2007.
22. Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology 9: 458-465, 2004.
23. American Thoracic Society/European Respiratory Society Task Force. Standards for the Diagnosis and Management of Patients with COPD [Internet]. Version 1.2. New York: American Thoracic Society; 2004 http://www.thoracic.org/go/copd. Date last updated: September 8 2005. Date last accessed: July 30 2007.
24. Pinto-Plata VM, Mullerova H, Toso JF, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 61: 23-28, 2006.
25. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166: 111-117, 2002.
26. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 152: 1107-1136, 1995.
27. Japanese Respiratory Society. The predicted values of spirometry and arterial blood gas analysis in Japanese. J Jpn Resp Soc 39: Appendix, 2001 (in Japanese).
28. Doherty TJ. Invited review: Aging and sarcopenia. J Appl Physiol 95: 1717-1727, 2003.
29. Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci 57: B359-B365, 2002.
30. Kennedy RL, Chokkalingham K, Srinivasan R. Obesity in the elderly: who should we be treating, and why, and how? Curr Opin Clin Nutr Metab Care 7: 3-9, 2004.
31. Koehler F, Doehner W, Hoernig S, et al. Anorexia in chronic obstructive pulmonary disease - association to cachexia and hormonal derangement. Int J Cardiol 119: 83-89, 2007.
32. Mannix ET, Manfredi F, Farber MO. Elevated O2 cost of ventilation contributes to tissue wasting in COPD. Chest 115: 708-713, 1999.
33. Pijl H, Meinders AE. Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Saf 14: 329-342, 1996.
34. Calverley PM. The role of corticosteroids in chronic obstructive pulmonary disease. Semin Respir Crit Care Med 26: 235-245, 2005.
35. Warne JP. Tumour necrosis factor alpha: a key regulator of adipose tissue mass. J Endocrinol 177: 351-355, 2003.
36. Bamia C, Trichopoulou A, Lenas D, Trichopoulos D. Tobacco smoking in relation to body fat mass and distribution in a general population sample. Int J Obes Relat Metab Disord 28: 1091-1096, 2004.
37. Shore SA. Obesity and asthma: implications for treatment. Curr Opin Pulm Med 13: 56-62, 2007.
38. Tomoda K, Yoshikawa M, Itoh T, et al. Elevated Circulating Plasma Adiponectin in Underweight Patients With COPD. Chest 132: 135-140, 2007.
39. Razak F, Anand SS, Shannon H, et al. Defining obesity cut points in a multiethnic population. Circulation 115: 2111-2118, 2007.
40. Steuten LM, Creutzberg EC, Vrijhoef HJ, Wouters EF. COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J 15: 84-91, 2006.
41. Marquis K, Maltais F, Duguay V, et al. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 25: 226-232, 2005.
42. Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis - part I: review of principles and methods. Clin Nutr 23: 1226-1243, 2004.